SLC9A3 and diabetic kidney disease: Based on the demonstration of the HG-enhanced activity and expression of NHE3 in mesangial cells, it can be hypothesized that NHE3 inhibition in these cells represents a potential mechanism by which SGLT2-Is could prevent glomerulosclerosis and ameliorate DKD [136].